logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anna K. Nowak

University of Western Australia
H指数:87
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA

IDHMT肿瘤患者在接受EORTC CATNON试验中辅助和/或同步替莫唑胺治疗的间变性星形细胞瘤中的预后和预测性生物标志物

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Van Den Bent, Martin; Ghisai, Santoesha; Erridge, Sara; Vogelbaum, Michael; Nowak, Anna; Sanson, Marc; Brandes, Alba; Wick, Wolfgang; Clement, Paul; Baurain, Jean Francois; Mason, Warren; Weller, Michael; Aldape, Kenneth; Wheeler, Helen; Wesseling, Pieter; Kros, Johan; Tesileanu, Mircea; Golfinopoulos, Vassilis; Baumert, Birgitta; Hoostrate, Youri; Gorlia, Thierry; French, Pim
Radiologist's Guide to the Ninth Edition TNM Staging System for Quantitative and Qualitative Assessment of Pleural Mesothelioma (vol 316, e250531, 2025)

放射科医师指南：第九版TNM分期系统对胸膜间皮瘤定量和定性评估的应用（卷316，e250531，2025）

RADIOLOGY
IF15.2
2025-10-010
PRE
Murphy, David J.; Nowak, Anna K.; Frauenfelder, Thomas; Ginsberg, Michelle S.; Kodama, Hiroshi; de Rosen, Veronica Lenge; Mayoral, Maria; Straus, Christopher; Benedetti, Giulia; Rusch, Valerie W.; Gill, Ritu R.
FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.

EORTC随机分组III期CATNON试验的最终临床和分子分析：关于无1p/19q共缺失的间变性胶质瘤中同步和辅助替莫唑胺的应用。

NEURO-ONCOLOGY
IF13.4
2025-10-010
OAAI
van den Bent, M. J.; Erridge, S.; Vogelbaum, M. A.; Nowak, A.; Sanson, M.; Brandes, A.; Wick, W.; Clement, P. M.; Baurain, J.; Mason, W.; Wheeler, H.; Weller, M.; Aldape, K.; Wesseling, P.; Kros, J. M.; Tesileanu, M.; Golfonopoulos, V; Gorlia, T.; French, P.; Baumert, B. G.
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
ACTA NEUROPATHOLOGICA
IF9.3
2024-10-090
OA
Ghisai, Santoesha A.; van Hijfte, Levi; Vallentgoed, Wies R.; Tesileanu, C. Mircea S.; de Heer, Iris; Kros, Johan M.; Sanson, Marc; Gorlia, Thierry; Wick, Wolfgang; Vogelbaum, Michael A.; Brandes, Alba A.; Franceschi, Enrico; Clement, Paul M.; Nowak, Anna K.; Golfinopoulos, Vassilis; van den Bent, Martin J.; French, Pim J.; Hoogstrate, Youri
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

抗代谢物化疗增加表达LAG-3的肿瘤浸润淋巴细胞，可通过联合免疫检查点阻断靶向

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-09-280
OAAI
Principe, Nicola; Phung, Amber-Lee; Stevens, Kofi L. P.; Elaskalani, Omar; Wylie, Ben; Tilsed, Caitlin M.; Sheikh, Fezaan; Morales, M. Lizeth Orozco; Kidman, Joel; Marcq, Elly; Fisher, Scott A.; Nowak, Anna K.; Mcdonnell, Alison M.; Lesterhuis, W. Joost; Chee, Jonathan
Updated survival and vaccine response from the NIPU trial: A randomised, phase II study evaluating nivolumab and ipilimumab with or without UV1 vaccination in patients with pleural mesothelioma

NIPU试验的更新生存数据和疫苗反应：一项评估纳武利尤单抗和伊匹木单抗联合或不联合UV1疫苗接种在胸膜间皮瘤患者中的随机Ⅱ期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Haakensen, V. D.; Ojlert, A. K.; Kefi, W.; Thunold, S. M. H.; Farooqi, S. J.; Nowak, A. K.; Chin, W. L.; Grundberg, O.; Szejniuk, W. M.; Cedres Perez, S. M.; Sorensen, J. B.; Dalen, T. S.; Lund-Iversen, M.; Bjaanaes, M. M.; Inderberg, E. M.; Helland, A.
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/-UV1 telomerase vaccine
European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2024-08-120
OAAI
Thunold, Solfrid; Hernes, Eivor; Farooqi, Saima; Oejlert, asa Kristina; Francis, Roslyn J.; Nowak, Anna K.; Szejniuk, Weronika Maria; Nielsen, Soren Steen; Cedres, Susana; Perdigo, Marc Simo; Sorensen, Jens Benn; Meltzer, Carin; Mikalsen, Lars Tore Gyland; Helland, Aslaug; Malinen, Eirik; Haakensen, Vilde Drageset
Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention

高级别神经胶质瘤患者的未满足需求: 确定阶梯式护理干预的标准

JNCI CANCER SPECTRUM
IF4.1
2024-05-101
OAAI
Faris, Mona M.; Dhillon, Haryana M.; Campbell, Rachel; Halkett, Georgia K. B.; Miller, Annie; Chan, Raymond J.; Haydon, Helen M.; Sansom-Daly, Ursula M.; Koh, Eng-Siew; Ownsworth, Tamara; Nowak, Anna K.; Kelly, Brian; Leonard, Robyn; Pike, Kerryn E.; Legge, Dianne M.; Pinkham, Mark B.; Agar, Meera R.
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
ONCOIMMUNOLOGY
IF6.3
2024-04-262
OA
Kidman, Joel; Zemek, Rachael M.; Sidhom, John-William; Correa, Debora; Principe, Nicola; Sheikh, Fezaan; Fear, Vanessa S.; Forbes, Catherine A.; Chopra, Abha; Boon, Louis; Zaitouny, Ayham; de Jong, Emma; Holt, Robert A.; Jones, Matt; Millward, Michael J.; Lassmann, Timo; Forrest, Alistair R. R.; Nowak, Anna K.; Watson, Mark; Lake, Richard A.; Lesterhuis, W. Joost; Chee, Jonathan
An evidence-base for the implementation of hospital-based palliative care programs in routine cancer practice: A systematic review

在常规癌症实践中实施基于医院的姑息治疗计划的证据基础: 系统评价

PALLIATIVE MEDICINE
IF3.9
2023-07-089
OAAI
Rizvi, Farwa; Wilding, Helen Elizabeth; Rankin, Nicole M.; Le Gautier, Roslyn; Gurren, Lorna; Sundararajan, Vijaya; Bellingham, Kylee; Chua, Joyce; Crawford, Gregory B.; Nowak, Anna K.; Le, Brian; Mitchell, Geoff; McLachlan, Sue-Anne; Sousa, Tanara Vieira; Hudson, Robyn; IJzerman, Maarten; Collins, Anna; Philip, Jennifer

研究方向

暂未获取到该数据
R
Richard Lake
H 指数:48论文数:269被引数:1.1万
W
W. Joost Lesterhuis
H 指数:44论文数:174被引数:8,989
J
Jenette Creaney
H 指数:62论文数:234被引数:4.2万
M
Michael Millward
H 指数:61论文数:456被引数:1.6万
A
Alison M. McDonnell
H 指数:18论文数:33被引数:885
S
Scott Fisher
H 指数:23论文数:95被引数:1,624
G
Georgia Halkett
H 指数:34论文数:196被引数:4,063
H
Haryana M. Dhillon
H 指数:48论文数:379被引数:9,988
R
Rachael M. Zemek
H 指数:11论文数:33被引数:666
I
Ian M. Dick
H 指数:42论文数:172被引数:7,672